California is among a growing number of states that offer dental benefits to low-income residents, but some lawmakers want the state to go further by covering more cleanings and costlier implants. Dentists and health experts worry the approach doesn’t address the root of the problem: Many providers don’t accept Medicaid.
Ten states have not expanded Medicaid, leaving 1.5 million people ineligible for the state and federal insurance program and also unable to afford private insurance. Seven of those states are in the South, where expansion efforts may have momentum but where lawmakers say political polarization is holding them back.
As Congress pushes for Medicare to cover payment for anti-obesity drugs, Denmark — Ozempic maker Novo Nordisk’s home — has limited coverage of the drug after cost overruns “emptied all the money boxes in the entire public health system.”
Hospitals in several states are partnering with a private equity-backed company to offer combined emergency and urgent care in a single building. But patients may not realize prices vary between the two services — often by a lot.
Legal maneuvering, industry lobbying, and lax IRS oversight leave lots of room for “operating surpluses.”
The National Education Association, the nation’s largest union, told striking workers that their health coverage would be cut off Aug. 1 absent a deal on a new contract. Tensions have mounted after staff disrupted the union’s convention, at which President Joe Biden had been scheduled to speak.
As Vice President Kamala Harris appears poised to become the Democratic Party’s presidential nominee, health policy in general and reproductive health issues in particular are likely to have a higher profile. Harris has long been the Biden administration’s point person on abortion rights and reproductive health and was active on other health issues while serving […]
Although Novo Nordisk and Lilly lump together the pharmacies that compound semaglutide and tirzepatide with internet cowboys selling fake drugs, there is a distinction. The FDA has offered Americans little clarity about the vast gray and black markets for the drugs.
If she grabs the baton from President Joe Biden to become the new presumptive Democratic presidential nominee, Kamala Harris would widely be expected to take an aggressive stance in support of abortion access — hitting former President Donald Trump on an issue that could undermine his chances of victory.
Though the Trump administration established a voluntary, temporary program lowering insulin costs for some older Americans on Medicare, the mandatory price caps implemented through Biden’s Inflation Reduction Act go significantly further.
